Thank you. So much wisdom in your post. One thing I am not

New Post Public Reply Private Reply Replies (0) Message Board
patientgal Shuler #3427
Thank you. So much wisdom in your post.

One thing I am not concerned with is the treatments; I am not concerned about the time it may take to complete the additional experiments (whatever they may be) or any additional information the FDA has requested the company provide to validate the safety, efficacy & ownership of HemaXellerate. It is still my firm belief that the extent of the present delays go back to the Oregon State mishap as well as the fact that when HemaXellerate emerges finally, it will emerge with Orphan Drug status. I don't believe there will be an additional wait period for this. I believe when approval is at last announced, it will be so with Orphan Drug status.

I absolutely have 100% faith in the medicine and the doctor's creating it. Their reputations, discoveries and work history speak volumes.

When I discovered the major muck up by Oregon State and subsequently alerted the company to it (yes, that was me) judging by the amount of time it took for the USPTO to update the expiration coupled with knowing how the FDA works, I suspected there would be some major changes in the already processed paperwork. Nothing I found indicated that the application consideration would be halted pending these modifications. At least not in terms of evaluating the treatment...not the empirical data, legitimacy, etc., etc., And even after communicating with several lawyers and people in-the-know within pharma & regulations, I still do not know as the consensus is the level of difficulty will be dictated by the person in charge of the case. Protocol or no protocol, much depends on the person whose lap this submission fell in. That is government for you.

My concern now is Koos. To answer a great number of email and PM's: in short, yes, I am pissed, to some extent I feel used and over the past couple of days I have said to myself "what a dumb ass you are!" as I read through file after file after file of information relating to Koos. Yup, I married the science and neglected to thoroughly vet the in-law before doing so.

See, my problem is I have difficulty in wrapping my head around good people being intimately aligned with a POS. Sure, we all have some indirect connection with someone who is absolutely no good. But, as a person who is the antithesis to most things considered commonplace now (i.e., corruption, apathy, laziness, greed, etc., etc.,) I find it very hard to accept that a truly decent person (or people) can be aligned with people (or a person) whose aim is to inflict harm. The moment I figure out that someone who has entered my life is nothing but bad, I do all I can to rid myself of that person. I don't want to be at risk of being personally damaged nor do I want the guilt my association looming over my head. Ridding myself of such is not always an easy task however. So, discovering what I did about the doctors (professionally and personally) it never dawned on me that Koos would willfully function in a capacity that is so contrary to the doctors that essentially, he depends on. (Yeah, yeah, I know.)


I digress... as I have already pointed out, much of what I have read over the past several days has left me with a very bitter taste. I have even found myself going to Yahoo message boards to read the history of posts by that seemingly insane Joe_from_Weymouth poster. Though I am pretty sure he posts on iHub, he says much more on the Yahoo board since the posters have a great deal more latitude there. From what I have read thus far, do I think Dr. Ichim, Dr. Min, Dr. Suhy & Benitec have had any idea of what Koos has been up to in his past? Nope. Absolutely not!  Do I think Koos's shareholders have been a main concern of his in the past? Nope. Do I think that some of the very bad BMSN/ENTB financial decisions (i.e., Asher/Southridge) that he has made were done out of ignorance? Nope. Do I think that up until very recently there was a whole lot of wool being pulled over our eyes? Yup! Do I think that I am going to sit back and do nothing while I am royally screwed out of my money and treated with an inexplicable disregard? Nope!!!

What that means I don't know just yet. I am working on that one.

That is where I am with this presently as I continue to dig. Try to have a good weekend, most.


RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 247

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
AWS Boosts Agilix's AI Education in Sierra Leone

Updated Category News Views 44

Agilix Labs' Landmark Leap with AWS Just when you think you've got the grip on global education dynamics, a new wave hits your shores, this time courtesy of Agilix Labs and AWS. Agilix Labs snagged a grant from Amazon Web Services, carving a path that blends AI with educational equity in Sierra Leone. Now, if that doesn’t prick up investor ears or yank a few...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 228

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 189

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Rosti Group Expands with Alvi Acquisition

Updated Category News Views 6

Rosti Bets on Expansion with Alvi Buyout Rosti Group just rolled the dice big by swallowing Alvi Group, marking another bold move in the ever-swinging industrial and medical device manufacturing rodeo. Suddenly, we’re talking about a company with roughly 3,000 employees on its roster and a neat EUR 450 million in combined revenue. Don't overlook the power play...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 201

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
O-I Glass Faces Class Action: Investor Implications

Updated Category News Views 68

O-I Glass in Hot Water Over Misleading Statements I'll tell you, nothing gets my goat quite like uncovering deceptive practices in the corporate world. It seems O-I Glass, Inc. (NYSE: OI), might have played a fast one with its shareholders. The company is staring down the barrel of a class action lawsuit from Schall, Brown & Schwartz LLP, alleging they weren't entirely...

Continue Reading
Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 115

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading
Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 200

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
UAE Pioneers eATA Carnet System Beyond Europe

Updated Category News Views 39

Breaking Tradition with Digital Innovation Well, who would’ve thought? The UAE just leapt ahead in the trade game, becoming the first to roll out the eATA Carnet system beyond the cozy confines of Europe. This isn’t some run-of-the-mill tech rollout, folks. It’s a digital revolution in how temporary imports are handled—goodbye paper, hello efficiency! With this...

Continue Reading
"More News Articles" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles